Mounjaro, a recently approved medication, is generating considerable excitement within the metabolic care field . This dual-action injectable drug combines a GLP-1 receptor agonist with a glucose-responsive https://alyssagujo844728.blog5.net/93582328/mounjaro-a-promising-hope-for-blood-sugar-control